Peer-Reviewed Publication
Front Digit Health2026;81851777.January 1, 2026Clinical Trial

Use of a digital health solution after percutaneous coronary intervention: a randomised controlled trial.

Elias Freyr Gudmundsson1, Bartosz Dobies1,2, Brynja Laxdal3, Inga Valborg Olafsdottir3, Ingibjörg Davidsdottir3, Heida Birna Bragadottir1, Svala Sigurdardottir1,4,5, Ari Pall Isberg1, Andrew Grannell1, Berglind Libungan3, Brynjolfur A Mogensen3, Hulda Halldorsdottir3, Maria V Gudmundsdottir3, Bylgja Kaernested3, Tryggvi Thorgeirsson1, Saemundur Jon Oddsson1, David O Arnar3,4
1Sidekick Health, Reykjavik, Iceland.
2Doctoral School of Medical and Health Sciences, Jagiellonian University Medical College, Krakow, Poland.
3Cardiovascular Services, Landspitali University Hospital, Reykjavik, Iceland.
4School of Health Sciences, University of Iceland, Reykjavik, Iceland.
5Center for Mindfulness, Clinical Medicine, Aarhus University, Aarhus, Denmark.

Abstract

AIMS: To evaluate a multimodal digital health intervention (SK-121) as an adjunct to standard of care (SoC) to reduce the risk of recurrent cardiovascular events in patients following percutaneous coronary intervention (PCI). METHODS AND RESULTS: In this single-centre, randomised controlled trial of 200 patients (mean age 64.4 years; 79.5% male) who underwent PCI, patients were randomised 1:1 to…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.